Purpose
With this call, the Novo Nordisk Foundation wishes to support the cardiometabolic research environment in the Nordic countries, while enhancing the use of ‘Danish Center for Strategic Research in Type 2 Diabetes’ (DD2) data, with a particular focus on promoting DD2 to new and external researchers.
The purpose of the call ‘DD2 Research Grant’ is to promote cohort-related research within the field of cardiometabolic diseases (CMDs), while maintaining and improving a unique Danish type 2 diabetes (T2D) resource. Using DD2 data, projects supported by the ‘DD2 Research Grant’ should lead to better understanding, treatment and prevention of T2D complications, its interactions with other CMDs and improved quality of life for people with T2D.
To find out more about the DD2 cohort profile, please refer to: https://dd2.dk/forskning/projektoversigt/projekter/dd2-cohort-profile
Important information
To use DD2 data for a research proposal, you must fill in and send a DD2 protocol which will be evaluated by the DD2 Scientific Advisory Board (https://dd2.dk/om-dd2/scientific-advisory-board).
If you need guidance in connection with the preparation of the protocol, you are welcome to contact research manager Kurt Højlund ([email protected]) and program manager Jens Steen Nielsen
([email protected]).
You can download the protocol template here or you can obtain the protocol template from DD2.
DD2 Symposium
To promote the call, DD2 hosts a symposium on 25 October 2024. The symposium will take place at the Steno Diabetes Center Copenhagen in Herlev. Please contact DD2 for more information and to sign up for the symposium: https://dd2.dk/forskning/seminar